Stock Taper
OCEA
OCEAN BIOMEDICAL, INC.
OTC
$0.00
▲ UP 25.00% (0.00)

KEY STATISTICS

Market Cap$593.18 K
52w High$0.01
52w Low$0.00
Dividend Yield
Frequency
P/E
Volume10.27K
Shares Out.232.37M

COMPANY

LEADERSHIP

Inderjote Kathuria
CHIEF EXECUTIVE
Inderjote Kathuria

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 8, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
7

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.
DEC
2
WED

PRICE

$0.00 ▲ UP 25.00% (+$0.00)
$0.00$0.00$0.00$0.00$0.00$0.009:30 AM10:15 AM10:59 AM11:44 AM12:28 PM1:13 PM1:57 PM0.00

About Ocean Biomedical, Inc.

http://www.oceanbiomedical.com ↗

Ocean Biomedical, Inc. is a Providence-based biopharma company developing monoclonal antibodies, small molecules, and vaccines targeting cancer, fibrosis, infectious diseases, and inflammation.

INDUSTRY

Biotechnology

A SERVICE OCEAN BIOMEDICAL, INC. IS KNOWN FOR

Clinical Pipeline of Therapeutic Candidates

Ocean Biomedical develops drugs and vaccines targeting oncology, fibrosis, and infectious diseases, including a malaria vaccine, cancer immunotherapies, and pulmonary fibrosis treatments, currently in various R&D stages.

COMPETITORS

SECTORS PEERS

PEERPRICE
PRE$25.63COMPARE
SABS$3.71COMPARE
SRZN$22.27COMPARE
KTTA$0.60COMPARE
CERO$0.01COMPARE
VINC$0.01COMPARE
BACK$0.00COMPARE
VRPX$0.00COMPARE